Healthcare - Biotechnology - NASDAQ - US
$ 2.19
11.7 %
$ 9.56 M
Market Cap
-0.15
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
100.00%
Net Income
Estimate
91.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SeaStar Medical Holding Corporation
ICU has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ICU
EBIT FORECAST
EBIT Forecast Chart ICU
NET INCOME FORECAST
Net Income Chart ICU